English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52847940    Online Users :  744
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsu c"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 771-820 of 881  (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2011-04 Overexpression of 14-3-3 epsilon predicts tumour metastasis and poor survival in hepatocellular carcinoma Ko, BS;Chang, TC;Hsu, C;Chen, YC;Shen, TL;Chen, SC;Wang, J;Wu, KK;Jan, YJ;Liou, JY
國家衛生研究院 2011-02 Concurrent chemoradiotherapy with cetuximab plus twice-weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma Lin, C;Hsu, C;Cheng, JC;Yen, C;Shiah, H;Lee, J;Wang, H;Yeh, K;Cheng, A;Lee, Y
國家衛生研究院 2011-02 Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers Yeh, K;Shen, Y;Li, C;Yen, C;Hsu, C;Lin, Z;Chen, L;Su, W;Chao, Y;Cheng, A
國立政治大學 2011 The design of the mobile service: Fit between mobility and customer variability Chang, Hsin-Lu;Lin, J.-R.;Wang, K.;Hsu, C.;Tai, J.C.-F.; 張欣綠
臺大學術典藏 2011 Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Yu C.-W.; Hsu C.; Hu F.-C.; CHIH-HUNG HSU; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Shen Y.-C.; Hsu C.-Y.; Hsu C.-Y. ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Chih-Hung Hsu ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.
臺大學術典藏 2011 Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era Cheng A.L.; YEN-SHEN LU; Kuo W.H; Chen I.C; Lin C.H; Huang C.S; Lien H.C; Hsu C; Chen I.C;Lin C.H;Huang C.S;Lien H.C;Hsu C;Kuo W.H;Yen-Shen Lu;Cheng A.L.
臺大學術典藏 2011 Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil Chen B.-B.; Hsu C.-H.; Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Wei S.-Y.; Cheng A.-L.; TIFFANY TING-FANG SHIH
國家衛生研究院 2010-01-30 Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B Ko, BS;Chang, TC;Chen, CH;Liu, CC;Kuo, CC;Hsu, C;Shen, YC;Shen, TL;Golubovskaya, VM;Chang, CC;Shyue, SK;Liou, JY
國家衛生研究院 2010 Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach Shen, YC;Hsu, C;Chen, LT;Cheng, CC;Hu, FC;Cheng, AL
國家衛生研究院 2009-10 Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma Jan, YJ;Ko, BS;Hsu, C;Chang, TC;Chen, SC;Wang, J;Liou, JY
國家衛生研究院 2009-09-15 Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Ou, DL;Shen, YC;Liang, JD;Liou, JY;Yu, SL;Fan, HH;Wang, DS;Lu, YS;Hsu, C;Cheng, AL
國家衛生研究院 2009-05-20 Helicobacter pylori-independent MALT lymphoma patients responsive to thalidomide-the molecular mechanism and the clinical application Kuo, S;Chen, L;Wu, M;Hsu, C;Lin, C;Hsu, P;Yeh, K;Tzeng, Y;Cheng, A
國家衛生研究院 2009-04-24 Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen, KF;Yeh, PY;Hsu, C;Hsu, CH;Lu, YS;Hsieh, HP;Chen, PJ;Cheng, AL
國立臺灣大學 2009-04 Frame Misalignment: Interpreting the Implementation of Information Systems Security Certification in an Organization Hsu, C.
國立臺灣大學 2009-03 The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Lin, ZZ; Hsu, HC; Hsu, CH; Yeh, PY; Huang, CY; Huang, YF; Chen, TJ; Kuo, SH; Hsu, C; Hu, FC; Jeng, YM; Chung, Y; Cheng, AL.
國家衛生研究院 2009-02 Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival Shen, YC;Hu, FC;Jeng, YM;Chang, YT;Lin, ZZ;Chang, MC;Hsu, C;Cheng, AL
國家衛生研究院 2009 Adjuvant interferon therpay after curative therapy for hepatocellular carcinoma (HCC): A meta-analysis Hsu, C;Shen, Y;Chen, L;Cheng, C;Hu, F;Cheng, A
高雄醫學大學 2009 軟珊瑚Nephthea erecta and N. chabrolizp 分離純化的sesquiterpenes and norergosterol  鄭旭益;溫世宏;邱素芬;王雙桂;戴昌鳳;杜昌益  ; Cheng SY;Huang YC;Wen ZH;Chiou SF;Wang SK;Hsu C;Dai CF;Duh CY
國立臺灣大學 2009 Creating Experience Economy in E-Commerce Chang, W.; Yuan, S.T.; Hsu, C.
臺大學術典藏 2009 Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy Chen P.-J.; Cheng A.-L.; SHU-CHEN WEI; Hsu C.
國家衛生研究院 2008-12 Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial Hsu, C;Kuo, SH;Hu, FC;Cheng, AL;Shih, JY;Yu, CJ;Lin, CC;Huang, TC;Yang, PC;Yang, CH
國立政治大學 2008-12 Teachers’ perceptions of the dimensions and implementation of technology leadership of principals in Taiwanese elementary schools Chang, I.;秦夢群;Hsu, C.; Chang, I.;Chin, J.M.;Hsu, C.
元智大學 2008-05 線上遊戲設計: 分析架構與個案探討 邱昭彰; Jen, E F; Hsu, C.
國家衛生研究院 2008-03 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Chao, TY; Liu, TW; Cheng, AL; Chen, PJ
國立臺灣大學 2008-03 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin’s lymphoma: A randomized trial. Hsu, C; Hsiung, CA; Su, IJ; Hwang, WS; Wang, MC; Lin, SF; Lin, TH; Hsiao, HH; Young, JH; Chang, MC; Liao, YM; Li, CC; Wu, HB; Tien, HF; Cho, TY; Liu, TW; Cheng, AL; Chen, PJ
國立臺灣大學 2008-03 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by international prognostic scoring system, cytogenetic and genetic studies. Huang, TC; Ko, BS; Hsu, C; Chen, CY; Tsay, W; Tang, JL; Huang, SY; Yao, M; Chen, YC; Shen, MC; Wang, CH; Tien, HF
國家衛生研究院 2008 Expression of the nuclear factor kappa B (NFKB) P50/P65 proteins in hepatocellular carcinoma (HCC): Lack of predictive value for response to thalidomide treatment Hsu, C;Chen, LT;Chao, Y;Fan, HH;Shen, YC;Cheng, AL
臺北醫學大學 2008 Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis. 鄭建睿; Zou Y; Tsai WB; Cheng CJ; Hsu C; Chung YM; Li PC; Lin SH; Hu MC
臺大學術典藏 2008 Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment CHIH-HSIN YANG; Yang P.-C; Cheng A.-L; Lin C.-C; Hsu C.-H; Yu C.-J; Chang Y.-C; Chih-Hsin Yang;Yang P.-C;Cheng A.-L;Lin C.-C;Hsu C.-H;Yu C.-J;Chang Y.-C;Hsu C;Lin Z.-Z; Lin Z.-Z; Hsu C
臺大學術典藏 2008 Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers Hsu C.; JIN-YUAN SHIH; Yang C.-H.; Yu C.-J.; Lo Y.; Chen J.-P.
臺大學術典藏 2008 Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer Jan I.-S.; Wong J.-M.; Tsao P.-N.; Chang Y.-T.; Chang M.-C.; SHU-CHEN WEI; Tien Y.-W.; Hsu C.; Liang P.-C.
臺大學術典藏 2008 Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer Wong J.-M.; Jan I.-S.; PO-NIEN TSAO; Liang P.-C.; Hsu C.; Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.
臺大學術典藏 2008 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies Tien H.-F.; Shen M.-C.; Wang C.-H.; Chen Y.-C.; MING YAO; Huang S.-Y.; Tsay W.; Hsu C.; Chen C.-Y.; Tang J.-L.; Ko B.-S.; Huang T.-C.
臺大學術典藏 2008 A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial Chen P.-J.; Cheng A.-L.; Liu T.-W.; Chao T.-Y.; HWEI-FANG TIEN; Wu H.-B.; Li C.-C.; Liao Y.-M.; Young J.-H.; Chang M.-C.; Hsiao H.-H.; Lin T.-H.; Lin S.-F.; Wang M.-C.; Hwang W.-S.; Su I.-J.; Hsu C.; Hsiung C.A.
臺大學術典藏 2008 Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies Tien H.-F.; Wang C.-H.; Shen M.-C.; Chen Y.-C.; Yao M.; Huang T.-C.; BOR-SHENG KO; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.
國立臺灣大學 2007-12 Strategic planning of developing automatic optical inspection (AOI) technologies in Taiwan Hsu, C.; Fan, K.C.
中原大學 2007-08 Photoluminescence Studies in Anodic Aluminum Oxide Membranes Yang, M. D.;Chen, K. W.;Shen, J. L.;Hsu, C.
國家衛生研究院 2007-05 Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result Liang, PC; Ch'ang, HJ; Hsu, C; Tseng, SS; Shih, TTF; Liu, TW
元智大學 2007-05 Mining three-dimensional anthropometric body surface scanning data for hypertension detection 邱昭彰; Hsu, G; Hsu, P.; Hsu, C.
國立臺灣大學 2007-03 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang, YT; Hsu, C; Jeng, YM; Chang, MC; Wei, SC; Wong, JM
國立臺灣大學 2007-02 A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH.
國立臺灣大學 2007-02 A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer. Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH.
國家衛生研究院 2007 A prospective comparative study of prophylactic or therapeutic use of lamivudine for chemotherapy-associated hepatitis B (HBV) reactivation in nowhodgkin's lymphoma (NHL) patients Hsu, C;Hsiung, CA;Su, LJ;Hwang, WS;Wang, MC;Lin, SF;Lin, TH;Hsiao, HH;Young, JH;Chang, MC;Huang, MJ;Liao, YM;Li, CC;Wu, HB;Chao, TY;Liu, TW;Cheng, AL;Chen, PJ
臺北醫學大學 2007 The molecular events occur during MK-801-induced cytochrome oxidase subunit II down-regulation in GT1-7 cells. 李文森; Lee TY; Tsai KL; Lee WS; Hsu C
臺大學術典藏 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang, YT;Hsu, C;Jeng, YM;Chang, MC;Wei, SC;Wong, JM; Chang, Y.-T. and Hsu, C. and Jeng, Y.-M. and Chang, M.-C. and Wei, S.-C. and Wong, J.-M.; Chang, YT; YUNG-MING JENG; YU-TING CHANG; Hsu, C; Jeng, YM; Chang, MC; Wei, SC; Wong, JM
臺大學術典藏 2007 Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial Yang C.-H.;Cheng A.-L;Hsu W.-L;Hsu C.-H;Hsu C;Chia-Chi Lin; Chia-Chi Lin; Hsu C; Hsu C.-H; Hsu W.-L; Cheng A.-L; Yang C.-H.
臺大學術典藏 2007 Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: A preliminary result Liang P.-C.; Ch'ang H.-J.; Hsu C.; Tseng S.S.; TIFFANY TING-FANG SHIH; Wu Liu T.
臺大學術典藏 2007 Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma Chang Y.-T.; Hsu C.; Jeng Y.-M.; Chang M.-C.; SHU-CHEN WEI; Wong J.-M.
元智大學 2006-12 Mining Flow-time in Wafer Manufacturing Processes using Constraint-Based Evolutionary Regression Trees 張百棧; 邱昭彰; Hsu, P.; Hsu, C.
國立臺灣大學 2006-09 CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma Su, M. C.; Hsu, C.; Kao, H. L.; Jeng, Y. M.

Showing items 771-820 of 881  (18 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page